StonvexLoading…
StonvexCore line items from BGC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $797.71M | $2.44B | $1.80B | $1.18B |
Operating Income | $115.45M | $213.75M | $188.75M | $155.26M |
Net Income | $84.15M | $154.96M | $140.59M | $112.71M |
EPS (Diluted) | $0.17 | $0.31 | $0.28 | $0.22 |
Total Assets | $5.86B | $4.41B | $5.83B | $4.89B |
Total Liabilities | $4.59B | $3.27B | $4.68B | $3.78B |
Cash & Equivalents | $780.98M | $851.50M | $774.94M | $827.84M |
Free Cash Flow OCF − CapEx | $15.37M | $372.87M | $197.74M | $60.55M |
Shares Outstanding | 479.22M | 480.95M | 482.86M | 485.09M |